Friday, October 6, 2017

ACLU Sues to Force Every Pharmacy in America to Sell the Abortion Drug to Kill Babies


By Micaiah Bilger
Life News


A Hawaii abortion activist is suing the federal government in a case that could force every pharmacy in America to sell dangerous abortion drugs.

Dr. Graham Chelius, an ob-gyn in Waimea, Hawaii, is suing the FDA and the U.S. Department of Health and Human Services with the help of the American Civil Liberties Union.

In the lawsuit filed Tuesday, the ACLU argues that the FDA is restricting women’s access to abortion by requiring that the abortion drug be dispensed at a medical facility under the supervision of a certified provider (not necessarily even a doctor), KHON News 2 reports.

Chelius and the pro-abortion legal group want the FDA to allow pharmacies to give out the abortion drug mifeprex, also known as mifepristone or RU-486.

The abortion drug works by blocking the hormone progesterone, causing the uterine wall to break down and basically suffocating the unborn baby. A second abortion drug, misoprostol, typically is taken a day or two later to induce contractions to expel the dead baby’s body.

Because of the high failure rate and the risks involved with the abortion drug in later pregnancies, the FDA limited approval for use only in the first 49 days from the start of a woman’s last menstrual period. However, last year under pro-abortion President Barack Obama’s administration, the FDA changed its guidelines for the drug, allowing it to be used later in pregnancy and in smaller doses.
Now, abortion activists are pushing for even fewer regulations.  NPR reports more about the lawsuit:

The suit, filed Tuesday in federal court in Hawaii, challenges a longstanding U.S. Food and Drug Administration regulation allowing the abortion pill, Mifeprex, to be dispensed only at a medical facility under the care of a certified provider. Among other requirements, those providers must pre-register with the drug manufacturer, keep the medication in stock, and be capable of providing a surgical abortion if complications arise.

Chelius argues those rules are unnecessary and cumbersome. Hawaii has one of the nation’s highest poverty rates, and the delays and expenses are sometimes insurmountable barriers, Chelius said. The case could have implications beyond Hawaii.

“The FDA restrictions create delays that often push medication abortion out of reach of my patients,” he said. “And some of my patients are simply unable to make this trip and instead have been forced to carry a pregnancy to term against their will.”

No comments:

Post a Comment